Peking University is a national public research university in Beijing, China. The university is funded by the Ministry of Education. Peking University was established as the Imperial University of Peking in 1898 when it received its royal charter by the Guangxu Emperor.

During the past decade, Peking University conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 2 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peking University" #1 sponsor was "Peking University" with 13 trials, followed by "Beijing Friendship Hospital" with 2 trials sponsored, "Duke University" with 1 trials sponsored, "Karolinska Institutet" with 1 trials sponsored and "University Hospitals Cleveland Medical Center" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peking University" #1 collaborator was "Peking University" with 5 trials as a collaborator, "Beijing 302 Hospital" with 2 trials as a collaborator, "Beijing Ditan Hospital" with 2 trials as a collaborator, "Beijing Tiantan Hospital" with 2 trials as a collaborator and "Beijing YouAn Hospital" with 2 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Peking University" are "Liver Cirrhosis" (2 trials), "Obesity" (2 trials), "Advanced Hepatocellular Carcinoma" (1 trials), "Age-related Macular Degeneration" (1 trials) and "Air Pollution" (1 trials). Many other conditions were trialed in "Peking University" in a lesser frequency.

Most popular intervention types in "Peking University" are "Behavioral" (7 trials), "Other" (7 trials), "Drug" (4 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "No intervention" (2 trials), "Thymosin-α" (2 trials), "Acupuncture" (1 trials), "Air pollutants" (1 trials) and "Air purifier" (1 trials). Other intervention names were less common.

The vast majority of trials in "Peking University" are 19 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Peking University". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Peking University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Peking University, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".